Legal Representation
Attorney
David L. May
USPTO Deadlines
Application History
43 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 27, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Oct 27, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
Mar 14, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 13, 2014 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Mar 11, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 11, 2014 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Sep 25, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 24, 2013 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Sep 13, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 13, 2013 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Mar 2, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 1, 2013 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Feb 28, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 28, 2013 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Sep 7, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Sep 6, 2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Sep 6, 2012 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Sep 5, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Sep 5, 2012 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Mar 22, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Mar 20, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Mar 20, 2012 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Mar 20, 2012 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Sep 20, 2011 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jul 26, 2011 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 26, 2011 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 17, 2011 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jun 17, 2011 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
Jun 3, 2011 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Jun 3, 2011 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 3, 2011 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Jun 3, 2011 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jun 3, 2011 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 1, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 31, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 31, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 29, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 29, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 29, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 26, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 17, 2010 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
Aug 14, 2010 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 13, 2010 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene express
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical reagents for medical and veterinary purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; Medical services, namely, gene therapy services
First Use Anywhere:
0
First Use in Commerce:
0
Class 045
Technology transfer services, namely, licensing of intellectual property
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
RHEO GENE
Classification
International Classes
001
005
042
044
045